Skip to main content

Champions Oncology, Inc.

CSBR
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
SEC CIK
0000771856

No open-market purchases or sales by Champions Oncology, Inc. insiders were filed in the last 90 days; 28 institutions reported holding it in 13F filings for Q2 2026, worth $36.3M in total; no superinvestor holds it.

13F holders, Q2 2022

Institutional positions in Champions Oncology, Inc. as of Jun 30, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works

Institutional holders
32
+3 vs. Q1 2022
Shares held
6.22M
+52.5K (+0.9%) vs. Q1 2022
Total value
$49.8M
−$350.0K (−0.7%) vs. Q1 2022
New holders
3
6 more added
Sold out
0
6 more reduced

1 institution that held it in Q1 2022 haven't filed for Q2 2022 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.

Compare with Q1 2022: new holders, sold out and not filed yet

Holders and value by quarter

Institutions reporting CSBR on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.

Institutional holdersQ2 2022: 32 institutions
Q1 2021: 45 institutionsQ2 2021: 38 institutionsQ3 2021: 35 institutionsQ4 2021: 31 institutionsQ1 2022: 30 institutionsQ2 2022: 32 institutionsQ3 2022: 32 institutionsQ4 2022: 29 institutionsQ1 2023: 30 institutionsQ2 2023: 28 institutionsQ3 2023: 29 institutionsQ4 2023: 23 institutionsQ1 2024: 25 institutionsQ2 2024: 23 institutionsQ3 2024: 22 institutionsQ4 2024: 25 institutionsQ1 2025: 34 institutionsQ2 2025: 30 institutionsQ3 2025: 27 institutionsQ4 2025: 27 institutionsQ1 2026: 25 institutionsQ2 2026: 28 institutions
Value heldQ2 2022: $49.8M
Q1 2021: $81.4MQ2 2021: $68.5MQ3 2021: $64.1MQ4 2021: $51.7MQ1 2022: $50.4MQ2 2022: $49.8MQ3 2022: $46.8MQ4 2022: $27.1MQ1 2023: $23.6MQ2 2023: $37.0MQ3 2023: $35.6MQ4 2023: $31.5MQ1 2024: $27.6MQ2 2024: $29.9MQ3 2024: $28.2MQ4 2024: $49.0MQ1 2025: $51.4MQ2 2025: $42.5MQ3 2025: $36.7MQ4 2025: $39.7MQ1 2026: $33.0MQ2 2026: $36.3M
Institutions holding CSBR and their total value by quarter
QuarterHoldersValue
Q2 202628$36.3M
Q1 202625$33.0M
Q4 202527$39.7M
Q3 202527$36.7M
Q2 202530$42.5M
Q1 202534$51.4M
Q4 202425$49.0M
Q3 202422$28.2M
Q2 202423$29.9M
Q1 202425$27.6M
Q4 202323$31.5M
Q3 202329$35.6M
Q2 202328$37.0M
Q1 202330$23.6M
Q4 202229$27.1M
Q3 202232$46.8M
Q2 202232$49.8M
Q1 202230$50.4M
Q4 202131$51.7M
Q3 202135$64.1M
Q2 202138$68.5M
Q1 202145$81.4M

Institutions, Q2 2022

Shares, value and share of portfolio for each institution holding Champions Oncology, Inc.; share changes are against Q1 2022.

Institutions holding CSBR in Q2 2022
InstitutionSharesValue% of portfolioChange in sharesAction
Battery Management Corp.2,421,673$19.4M3.21%00.0%Unchanged
NEA Management Company, LLC1,713,720$13.7M0.70%00.0%Unchanged
Millrace Asset Group, Inc.354,041$2.83M2.65%+25,061+7.6%Added
Vanguard Group Inc345,843$2.77M0.00%00.0%Unchanged
Tocqueville Asset Management L.P.286,611$2.29M0.04%+34,150+13.5%Added
Renaissance Technologies LLC164,346$1.31M0.00%−5,593−3.3%Reduced
BlackRock Inc.123,359$988.0K0.00%+561+0.5%Added
Essex Investment Management Co LLC115,075$921.0K0.15%00.0%Unchanged
Dimensional Fund Advisors LP113,343$917.0K0.00%+1,424+1.3%Added
Ameriprise Financial Inc84,177$681.0K0.00%−873−1.0%Reduced
Overbrook Management Corp63,888$511.0K0.15%00.0%Unchanged
ACT Capital Management, LLC62,500$500.0K0.70%00.0%Unchanged
Millennium Management LLC52,548$425.0K0.00%−1,253−2.3%Reduced
ClariVest Asset Management LLC48,200$386.0K0.02%00.0%Unchanged
Geode Capital Management, LLC47,638$385.0K0.00%00.0%Unchanged
Aristides Capital LLC36,750$294.0K0.23%00.0%Unchanged
Acadian Asset Management LLC31,476$252.0K0.00%00.0%Unchanged
Bank of New York Mellon Corp30,775$246.0K0.00%00.0%Unchanged
Northern Trust Corp27,305$218.0K0.00%−128−0.5%Reduced
State Street Corp26,553$215.0K0.00%00.0%Unchanged
HighTower Advisors, LLC26,467$214.0K0.00%00.0%Unchanged
Citadel Advisors LLC16,597$134.0K0.00%+518+3.2%Added
Ingalls & Snyder LLC11,056$88.0K0.00%00.0%Unchanged
Globeflex Capital L P8,549$69.0K0.02%00.0%Unchanged
Morgan Stanley5,400$43.0K0.00%−1,406−20.7%Reduced
UBS Group AG2,000$16.0K0.00%−1,022−33.8%Reduced
Total Clarity Wealth Management, Inc.937$7.00K0.00%+937New
Royal Bank of Canada100$1.00K0.00%00.0%Unchanged
JPMorgan Chase & Co11$00.00%00.0%Unchanged
Wells Fargo & Company44$00.00%+3+7.3%Added
Simplex Trading, LLC94$00.00%+94New
Tower Research Capital LLC (TRC)33$00.00%+33New
Susquehanna Fundamental Investments, LLC––––Not filed